Last Updated:
Name Designation Appointment Date Status
Amresh Kumar Sinha

Appointed as Director since December 2023

 Director 16-Dec-2023 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Stenmax Pharmaceuticals Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.
Rajiv Kumar Singh

Appointed as Director since November 2019

 Director 26-Nov-2019 Current
Rakesh Kumar Thakur

Appointed as Director since November 2019

 Director 26-Nov-2019 Current
Sanjeev Kumar Das

Appointed as Director since January 2022

 Director 13-Jan-2022 Current

People Timeline

Explore the timeline of key personnel in Stenmax Pharmaceuticals Private Limited's leadership journey.

Contact Details
  • Address H. No. 32, Kh No. 18/3 Nangli Vihar, New Delhi Delhi, 110043, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 110043
  • Country India
  • Website -
Frequently Asked Questions
You can contact Stenmax Pharmaceuticals Private Limited through their registered address at H. No. 32, Kh No. 18/3 Nangli Vihar, New Delhi Delhi, 110043, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Stenmax Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • Amresh Kumar Sinha
  • RAJIV KUMAR SINGH
  • RAKESH KUMAR THAKUR
  • SANJEEV KUMAR DAS
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available